Cannabis company Medical Marijuana, Inc. (OTCPK: MJNA) announced Wednesday that its subsidiary Kannaway has launched its operations in Hong Kong.
"Our first Asian expansion has been a fantastic success in Japan and we now look forward to bringing our high-quality cannabidiol (CBD) products to Hong Kong as well," Kannaway CEO Blake Schroeder stated. "Hemp has a long history in the region and, according to MJBizDaily, China is the world’s largest hemp producer. Now, with the global popularity of CBD on the rise, we’re seeing the citizens of Hong Kong who want to go back to their roots use hemp-derived CBD.”
Kannaway will be hosting regional events to educate current and potential brand ambassadors on the many potential wellness benefits and financial opportunities of hemp-derived CBD oil.
More recent news from Medical Marijuana:
Medical Marijuana’s shares were trading 9.76% higher at $0.04 per share at the time of writing Thursday morning.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Missed the first wave of cannabis investments? Don’t make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth.
Join Benzinga PotProfits. Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising cannabis stocks poised for growth, even in a dull market. He leaves no bud unturned to bring you the juiciest potential double-digit opportunities!
Just this year, the PotProfits portfolio has seen smoking-hot gains like:
- 47.10% with $GTBIF
- 40.23% with $TCNNF
- 21.50% with $VFF